Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_23833 | 17 | 0.36 | Mlig455_016419 | Neo: - Age: - |
MYT1 | Mlig455_016419 {REF} {Length: 2682} {Pfam: Zinc finger, C2HC type [PF01530.20, score=79.8]} {Human: ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=130, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=125, Expect=3e-30]} {Mouse: ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=132, Expect=6e-33]; ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=1e-31]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=126, Expect=2e-30]} {Dmel: FBgn0263772, CG43689, [RH, Score=99.0, Expect=1e-21]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=121, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_2, dd_Smed_v6_80183_0_2, [Score=127, Expect=4e-34]} {RNA1310_143021} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.846 | 0.788 | 0.99984 | 1.00000 | |
RegionR2 | 3.748 | 0.788 | 0.36352 | 0.75826 | |
RegionR3 | 1.317 | 0.788 | 0.45925 | 0.96906 | |
RegionR4 | -1.414 | 0.788 | 0.99983 | 1.00000 | |
RegionR5 | -1.068 | 0.788 | 1.00000 | 1.00000 | |
RegionR6 | -0.971 | 0.788 | 0.99983 | 1.00000 | |
RegionR7 | -0.548 | 0.788 | 0.99985 | 1.00000 | |
RegionR8 | -0.219 | 0.788 | 0.99983 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.266 | 0.788 | 0.99983 | 1.00000 | |
RegenerationR2 | 0.043 | 0.788 | 0.71412 | 0.96142 | |
RegenerationR3 | 0.689 | 0.788 | 0.82764 | 0.99024 | |
RegenerationR4 | 2.655 | 0.788 | 0.52976 | 0.88409 | |
RegenerationR5 | -0.209 | 0.788 | 0.99980 | 1.00000 | |
RegenerationR6 | 2.579 | 0.788 | 0.43379 | 0.76010 | |
RegenerationBL | -0.544 | 0.788 | 0.99990 | 1.00000 | |
RegenerationTP | -0.342 | 0.788 | 0.99991 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_23833 | 17 | 0.36 | Mlig455_016419 | Neo: - Age: - |
MYT1 | 3 | - | 1.000 | - | 1.000 | 1.000 | - | Mlig455_016419 {REF} {Length: 2682} {Pfam: Zinc finger, C2HC type [PF01530.20, score=79.8]} {Human: ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=130, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=125, Expect=3e-30]} {Mouse: ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=132, Expect=6e-33]; ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=1e-31]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=126, Expect=2e-30]} {Dmel: FBgn0263772, CG43689, [RH, Score=99.0, Expect=1e-21]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=121, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_2, dd_Smed_v6_80183_0_2, [Score=127, Expect=4e-34]} {RNA1310_143021} |
2. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
2.743 | - | 0.988 | - | 0.839 | 0.916 | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
3. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
2.712 | - | 0.972 | - | 0.835 | 0.905 | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
4. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 2.7 | - | 0.995 | - | 0.865 | 0.840 | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
5. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
2.69 | - | 0.986 | - | 0.839 | 0.865 | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
6. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
2.687 | - | 0.986 | - | 0.839 | 0.862 | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
7. | MligTC455_10227 | 76 | 1.59 | Mlig455_023507, Mlig455_023516, Mlig455_023551 | Neo: - Age: - |
2.679 | - | 0.987 | - | 0.839 | 0.853 | - | Mlig455_023507 {REF} {Length: 1545} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.8]} {RNA1310_22533.3} {RNA815_23050} Mlig455_023516 {REF} {Length: 1641} {RNA1310_22533.3} {RNA815_23050} Mlig455_023551 {REF} {Length: 1638} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_26724.1} |
|
8. | MligTC455_10229 | 24 | 0.49 | Mlig455_023615 | Neo: - Age: - |
2.679 | - | 0.988 | - | 0.839 | 0.852 | - | Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050} | |
9. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
2.658 | - | 0.952 | - | 0.840 | 0.866 | - | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
10. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 2.637 | - | 0.988 | - | 0.801 | 0.848 | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
11. | MligTC455_53657 | 221 | 4.6 | Mlig455_039396 | Neo: - Age: - Region-enriched R2: 6.078/0.00340 |
2.632 | - | 0.979 | - | 0.817 | 0.836 | - | Mlig455_039396 {REF} {Length: 1026} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=21.0]} {RNA1509_40972} {RNA1310_35649.1, RNA1509_40972} {RNA1509_40972, RNA815_17004} | |
12. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
2.631 | - | 0.970 | - | 0.865 | 0.796 | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
13. | MligTC455_37701 | 47 | 0.98 | Mlig455_029831 | Neo: - Age: - Region-enriched R2: 8.298/0.02665 |
2.63 | - | 0.958 | - | 0.839 | 0.833 | - | Mlig455_029831 {REF} {Length: 724} {RNA1310_73844} | |
14. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
2.62 | - | 0.985 | - | 0.838 | 0.797 | - | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
15. | MligTC455_49285 | 164 | 3.41 | Mlig455_004486, Mlig455_037380 | Neo: - Age: - Region-specific R2: 6.095 Region-enriched R2: 5.942/0.00244 |
LEF1 | 2.616 | - | 0.954 | - | 0.810 | 0.852 | - | Mlig455_004486 {REF} {Length: 3612} {Pfam: HMG (high mobility group) box [PF00505.21, score=30.1]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [Score=105, Expect=2e-24]; ENSG00000081059, TCF7, transcription factor 7, [Score=103, Expect=3e-25]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [Score=100, Expect=2e-22]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [Score=105, Expect=6e-25]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [Score=101, Expect=8e-24]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [Score=100, Expect=1e-22]} {Dmel: FBgn0085432, pan, pangolin, [Score=103, Expect=1e-23]} {Celegans: WBGene00004077, pop-1, [Score=82.0, Expect=8e-17]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [Score=114, Expect=3e-29]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} Mlig455_037380 {REF} {Length: 3365} {Pfam: HMG (high mobility group) box [PF00505.21, score=78.7]; HMG-box domain [PF09011.12, score=32.5]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=156, Expect=1e-43]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=154, Expect=7e-41]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=154, Expect=3e-44]; ENSG00000148737, TCF7L2, transcription factor 7 like 2, [RH, Score=150, Expect=6e-44]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=157, Expect=9e-44]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=156, Expect=1e-41]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=153, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=155, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=104, Expect=4e-24]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=165, Expect=2e-48]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} |
16. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
2.614 | - | 0.980 | - | 0.834 | 0.800 | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
17. | MligTC455_12269 | 42 | 0.88 | Mlig455_062448 | Neo: - Age: - Region-enriched R2: 6.351/0.02912 |
2.6 | - | 0.966 | - | 0.828 | 0.806 | - | Mlig455_062448 {REF} {Length: 941} {RNA1310_43338} {RNA815_24238} | |
18. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 2.595 | - | 0.962 | - | 0.796 | 0.837 | - | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
19. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 2.59 | - | 0.987 | - | 0.855 | 0.748 | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
20. | MligTC455_13903 | 648 | 13.5 | Mlig455_013116 | Neo: - Age: logFC(26M/2M)=-1.026 Region-specific R2: 6.980 Region-enriched R2: 7.338/0.00000 |
2.582 | - | 0.974 | - | 0.758 | 0.850 | - | Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856} | |
21. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
2.575 | - | 0.964 | - | 0.840 | 0.771 | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
22. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 2.556 | - | 0.985 | - | 0.783 | 0.788 | - | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
23. | MligTC455_35103 | 102 | 2.12 | Mlig455_023928 | Neo: - Age: logFC(26M/2M)=-1.570 Region-enriched R2: 8.161/0.00000 |
OPN4 | 2.552 | - | 0.968 | - | 0.841 | 0.743 | - | Mlig455_023928 {REF} {Length: 2781} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=179.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=24.6]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.1]} {Human: ENSG00000122375, OPN4, opsin 4, [RH, Score=218, Expect=2e-65]} {Mouse: ENSMUSG00000021799, Opn4, opsin 4 (melanopsin), [RH, Score=225, Expect=1e-68]} {Dmel: FBgn0014019, Rh5, Rhodopsin 5, [RH, Score=222, Expect=2e-68]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=91.3, Expect=4e-20]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [RH, Score=520, Expect=0.0]} {RNA1509_41123} {RNA1310_10673, RNA1509_41123} {RNA1509_41123, RNA815_4962} |
24. | MligTC455_33850 | 80 | 1.67 | Mlig455_015720 | Neo: - Age: - Region-enriched R2: 4.134/0.00338 |
2.512 | - | 0.976 | - | 0.812 | 0.724 | - | Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453} | |
25. | MligTC455_48523 | 615 | 12.81 | Mlig455_027573 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.661 Region-enriched R2: 5.785/0.00008 |
2.5 | - | 0.972 | - | 0.782 | 0.746 | - | Mlig455_027573 {REF} {Length: 1106} {TRANSSPLICED} {Pfam: N-formylglutamate amidohydrolase [PF05013.14, score=30.2]} {RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1310_12591, RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1509_25119, RNA1509_35691, RNA1509_59740, RNA815_14574} | |
26. | MligTC455_42240 | 80 | 1.66 | Mlig455_038267 | Neo: - Age: Down-Up-Down |
2.477 | - | 0.963 | - | 0.753 | 0.761 | - | Mlig455_038267 {REF} {Length: 989} {RNA1310_36501} {RNA815_32545} | |
27. | MligTC455_36566 | 40 | 0.83 | Mlig455_053263 | Neo: - Age: - Region-enriched R2: 4.823/0.01830 |
1.89 | - | 0.974 | - | - | 0.916 | - | Mlig455_053263 {REF} {Length: 1228} {TRANSSPLICED} {RNA1310_99871} | |
28. | MligTC455_17394 | 41 | 0.85 | Mlig455_013077 | Neo: - Age: - |
1.881 | - | 0.984 | - | - | 0.897 | - | Mlig455_013077 {REF} {Length: 1066} {RNA1310_66954} {RNA815_27868} | |
29. | MligTC455_52527 | 28 | 0.58 | Mlig455_025836 | Neo: - Age: - |
FLVCR2 | 1.88 | - | 0.983 | - | - | 0.897 | - | Mlig455_025836 {REF} {Length: 2177} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=81.4]; Sugar (and other) transporter [PF00083.26, score=18.7]} {Human: ENSG00000119686, FLVCR2, feline leukemia virus subgroup C cellular receptor family member 2, [RH, Score=364, Expect=5e-119]} {Mouse: ENSMUSG00000034258, Flvcr2, feline leukemia virus subgroup C cellular receptor 2, [RH, Score=367, Expect=3e-120]} {Dmel: FBgn0033196, CG1358, [RH, Score=350, Expect=1e-114]} {Celegans: WBGene00015632, C09D4.1, Uncharacterized MFS-type transporter C09D4.1, [RH, Score=358, Expect=1e-116]} {Smed: dd_Smed_v6_7578_0_1, dd_Smed_v6_7578_0_1, [Score=335, Expect=3e-109]} {RNA1509_31725} {RNA1310_8852.1} {RNA815_14234} |
30. | MligTC455_46343 | 76 | 1.57 | Mlig455_008895, Mlig455_016535 | Neo: - Age: - |
1.859 | - | 0.893 | - | - | 0.966 | - | Mlig455_008895 {REF} {Length: 5485} {RNA1509_28528} {RNA1310_45684, RNA1509_28528} {RNA1509_28528, RNA815_21057} Mlig455_016535 {REF} {Length: 2868} {RNA1509_28528} {RNA1310_45684} {RNA815_21057} |
|
31. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 1.855 | - | 0.988 | - | - | 0.867 | - | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
32. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 1.847 | - | 0.990 | - | - | 0.857 | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
33. | MligTC455_51198 | 15 | 0.3 | Mlig455_043152 | Neo: - Age: - |
1.839 | - | 0.874 | - | - | 0.965 | - | Mlig455_043152 {REF} {Length: 2583} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=62.9]} {RNA1310_7738.1} {RNA815_28239} | |
34. | MligTC455_52926 | 9 | 0.18 | Mlig455_024897 | Neo: - Age: - |
1.838 | - | 0.999 | - | 0.839 | - | - | Mlig455_024897 {REF} {Length: 428} {NoTransDecoderORF} {RNA1310_119495} | |
35. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
1.834 | - | 0.986 | - | - | 0.848 | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
36. | MligTC455_26801 | 7 | 0.14 | Mlig455_024981 | Neo: - Age: - |
1.827 | - | 0.988 | - | 0.839 | - | - | Mlig455_024981 {REF} {Length: 847} {RNA1310_42506} {RNA815_41145} | |
37. | MligTC455_51807 | 28 | 0.59 | Mlig455_046394 | Neo: - Age: - |
GPSM2 | 1.824 | - | 0.961 | - | - | 0.863 | - | Mlig455_046394 {REF} {Length: 3388} {Pfam: Tetratricopeptide repeat [PF13424.8, score=114.4]; Tetratricopeptide repeat [PF13176.8, score=96.0]; Tetratricopeptide repeat [PF00515.30, score=94.3]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=55.0]; Tetratricopeptide repeat [PF13181.8, score=42.2]; Tetratricopeptide repeat [PF13374.8, score=32.8]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.1]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=542, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=532, Expect=1e-180]; ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=511, Expect=1e-172]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=530, Expect=2e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=7e-80]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=477, Expect=1e-159]} {RNA1310_18538} {RNA815_41322} |
38. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
1.821 | - | 0.992 | - | 0.829 | - | - | Mlig455_065030 {REF} {Length: 672} | |
39. | MligTC455_15884 | 26 | 0.54 | Mlig455_066451 | Neo: - Age: - Region-enriched R2: 9.632/0.00394 |
1.816 | - | 0.979 | - | - | 0.837 | - | Mlig455_066451 {REF} {Length: 1468} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} | |
40. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
1.814 | - | - | - | 0.839 | 0.975 | - | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
41. | MligTC455_47997 | 36 | 0.75 | Mlig455_053262, Mlig455_065031 | Neo: - Age: - |
1.804 | - | 0.988 | - | 0.816 | - | - | Mlig455_053262 {REF} {Length: 927} {RNA1310_55950} {RNA815_42062.2} Mlig455_065031 {REF} {Length: 926} {RNA1310_55950} {RNA815_42062.2} |
|
42. | MligTC455_08763 | 20 | 0.41 | Mlig455_061186 | Neo: - Age: - |
1.802 | - | 0.988 | - | 0.814 | - | - | Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132} | |
43. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
1.764 | - | 0.984 | - | - | 0.780 | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
44. | MligTC455_12607 | 22 | 0.46 | Mlig455_022861 | Neo: - Age: - |
1.762 | - | 0.967 | - | 0.795 | - | - | Mlig455_022861 {REF} {Length: 614} {TRANSSPLICED} {RNA1310_92283} | |
45. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 1.746 | - | 0.980 | - | - | 0.766 | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
46. | MligTC455_17299 | 538 | 11.21 | Mlig455_036559, Mlig455_057787 | Neo: - Age: - Region-enriched R2: 5.046/0.00000 |
1.743 | - | - | - | 0.792 | 0.951 | - | Mlig455_036559 {REF} {Length: 718} {RNA1509_57277} {RNA1310_52579, RNA1509_57277} {RNA1509_57277, RNA815_26706} Mlig455_057787 {REF} {Length: 741} {RNA1509_57277} {RNA1310_52579} {RNA815_26706} |
|
47. | MligTC455_40850 | 7 | 0.14 | Mlig455_042076 | Neo: - Age: logFC(26M/2M)=0.689 |
1.733 | - | - | - | 0.782 | 0.951 | - | Mlig455_042076 {REF} {Length: 3408} {Pfam: REJ domain [PF02010.17, score=59.0]; PKD domain [PF18911.2, score=26.8]; PKD domain [PF00801.22, score=26.0]} {RNA1509_8046} {RNA1310_93} {RNA815_2228} | |
48. | MligTC455_47197 | 155 | 3.24 | Mlig455_049096, Mlig455_049118 | Neo: - Age: - |
1.716 | - | 0.973 | - | - | 0.743 | - | Mlig455_049096 {REF} {Length: 3209} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=151, Expect=1e-37]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} Mlig455_049118 {REF} {Length: 3116} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=160, Expect=1e-40]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} |
|
49. | MligTC455_37444 | 4098 | 85.37 | Mlig455_005616, Mlig455_014433, Mlig455_057559, Mlig455_070182 | Neo: - Age: - Region-enriched R2: 1.909/0.00760 |
1.691 | - | 0.976 | - | - | 0.715 | - | Mlig455_005616 {REF} {Length: 641} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_014433 {REF} {Length: 626} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_057559 {REF} {Length: 1151} {RNA1310_107958} Mlig455_070182 {REF} {Length: 638} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1, RNA1509_33612} {RNA1509_33612, RNA815_13049.1} |
|
50. | MligTC455_53586 | 32 | 0.66 | Mlig455_061060 | Neo: - Age: - |
1.681 | - | 0.972 | - | - | 0.709 | - | Mlig455_061060 {REF} {Length: 1466} {RNA1310_93934} {RNA815_37442} | |
51. | MligTC455_47544 | 42 | 0.88 | Mlig455_055595, Mlig455_055624 | Neo: - Age: - |
RASL10B | 1.68 | - | 0.976 | - | - | 0.704 | - | Mlig455_055595 {REF} {Length: 1887} {Pfam: Ras family [PF00071.24, score=75.5]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=34.0]; AAA ATPase domain [PF13191.8, score=20.2]} {Human: ENSG00000270885, RASL10B, RAS like family 10 member B, [Score=151, Expect=2e-44]} {Mouse: ENSMUSG00000020684, Rasl10b, RAS-like, family 10, member B, [Score=151, Expect=2e-44]} {Dmel: FBgn0037326, CG14669, [Score=112, Expect=1e-28]} {Celegans: WBGene00004307, rap-1, Ras-related protein Rap-1, [Score=54.7, Expect=7e-09]} {Smed: dd_Smed_v6_13540_0_1, dd_Smed_v6_13540_0_1, [Score=186, Expect=3e-57]} {RNA1310_59421} {RNA815_58204} Mlig455_055624 {REF} {Length: 1840} {Pfam: Ras family [PF00071.24, score=74.4]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=33.3]; AAA ATPase domain [PF13191.8, score=19.8]} {Human: ENSG00000270885, RASL10B, RAS like family 10 member B, [Score=150, Expect=4e-44]} {Mouse: ENSMUSG00000020684, Rasl10b, RAS-like, family 10, member B, [Score=152, Expect=6e-45]} {Dmel: FBgn0037326, CG14669, [Score=111, Expect=2e-28]} {Celegans: WBGene00004307, rap-1, Ras-related protein Rap-1, [Score=56.2, Expect=2e-09]} {Smed: dd_Smed_v6_13540_0_1, dd_Smed_v6_13540_0_1, [Score=186, Expect=3e-57]} {RNA1310_59421} {RNA815_58204} |
52. | MligTC455_12978 | 63 | 1.31 | Mlig455_023948 | Neo: - Age: - |
1 | - | 1.000 | - | - | - | - | Mlig455_023948 {REF} {Length: 2929} {RNA1310_80095.1} | |
53. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 1 | - | 1.000 | - | - | - | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
54. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 1 | - | 1.000 | - | - | - | - | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
55. | MligTC455_33853 | 7 | 0.14 | Mlig455_029940 | Neo: - Age: - |
MGAT1 | 1 | - | 1.000 | - | - | - | - | Mlig455_029940 {REF} {Length: 2088} {Pfam: GNT-I family [PF03071.17, score=204.9]} {Human: ENSG00000131446, MGAT1, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase, [Score=153, Expect=4e-41]} {Mouse: ENSMUSG00000020346, Mgat1, mannoside acetylglucosaminyltransferase 1, [Score=166, Expect=4e-46]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=172, Expect=3e-48]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=144, Expect=2e-38]} {Smed: dd_Smed_v6_13024_0_1, dd_Smed_v6_13024_0_1, [Score=158, Expect=1e-43]} {RNA1310_114996} |
56. | MligTC455_52486 | 26 | 0.55 | Mlig455_064865 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_064865 {REF} {Length: 266} {NoTransDecoderORF} {RNA1310_16242} {RNA815_45500} | |
57. | MligTC455_09450 | 20 | 0.43 | Mlig455_065848 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_065848 {REF} {Length: 677} {NoTransDecoderORF} {RNA1509_58917} {RNA1310_15399.1, RNA1509_58917} {RNA1509_58917, RNA815_33885} | |
58. | MligTC455_46281 | 22 | 0.45 | Mlig455_016138 | Neo: Irradiation Age: - |
KDELR2 | 0.994 | - | 0.994 | - | - | - | - | Mlig455_016138 {REF} {Length: 2664} {TRANSSPLICED} {Pfam: ER lumen protein retaining receptor [PF00810.20, score=173.9]; Intermediate filament protein [PF00038.23, score=132.5]; Lamin Tail Domain [PF00932.21, score=37.2]} {Human: ENSG00000136240, KDELR2, KDEL endoplasmic reticulum protein retention receptor 2, [Score=293, Expect=2e-93]} {Mouse: ENSMUSG00000079111, Kdelr2, KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2, [Score=296, Expect=1e-94]} {Dmel: FBgn0267330, KdelR, KDEL receptor, [Score=291, Expect=4e-93]} {Celegans: WBGene00001331, erd-2, ER lumen protein-retaining receptor, [Score=266, Expect=2e-83]} {Smed: dd_Smed_v6_1592_0_1, dd_Smed_v6_1592_0_1, [Score=283, Expect=8e-90]} {RNA1509_3479} {RNA1310_8292} {RNA815_3092.1} |
59. | MligTC455_01851 | 6 | 0.13 | Mlig455_052894 | Neo: - Age: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_052894 {REF} {Length: 177} {NoTransDecoderORF} | |
60. | MligTC455_00163 | 6 | 0.12 | Mlig455_060214 | Neo: - Age: - |
0.99 | - | - | - | - | 0.990 | - | Mlig455_060214 {REF} {Length: 1746} {Pfam: Pentapeptide repeats (8 copies) [PF00805.24, score=45.4]} {RNA1310_79710.2} | |
61. | MligTC455_23176 | 7 | 0.14 | Mlig455_005045 | Neo: - Age: Up-Down-Down |
RILPL1 | 0.99 | - | - | - | - | 0.990 | - | Mlig455_005045 {REF} {Length: 1392} {TRANSSPLICED} {Pfam: JNK_SAPK-associated protein-1 [PF09744.11, score=119.4]} {Human: ENSG00000188026, RILPL1, Rab interacting lysosomal protein like 1, [Score=77.0, Expect=9e-15]} {Mouse: ENSMUSG00000029392, Rilpl1, Rab interacting lysosomal protein-like 1, [Score=84.3, Expect=2e-17]} {Dmel: FBgn0024985, CG11448, [Score=130, Expect=5e-33]} {Celegans: WBGene00007860, rilp-1, RILP (Rab7-Interacting Lysosomal Protein) homolog, [Score=102, Expect=1e-23]} {Smed: dd_Smed_v6_4713_0_1, dd_Smed_v6_4713_0_1, [Score=156, Expect=3e-43]} {RNA1509_18713} {RNA1310_21261.1} {RNA815_18527} |
62. | MligTC455_43782 | 48 | 1 | Mlig455_044623, Mlig455_044681 | Neo: - Age: Up-Down-Up |
0.99 | - | - | - | - | 0.990 | - | Mlig455_044623 {REF} {Length: 2203} {RNA1310_60578} {RNA815_63573} Mlig455_044681 {REF} {Length: 2217} {Pfam: Glycine rich protein [PF12810.9, score=37.4]} {RNA1310_60578} {RNA815_63573} |
|
63. | MligTC455_01861 | 30 | 0.63 | Mlig455_046027 | Neo: - Age: - |
0.989 | - | 0.989 | - | - | - | - | Mlig455_046027 {REF} {Length: 736} {RNA1310_50531} {RNA815_29422} | |
64. | MligTC455_06475 | 3 | 0.06 | Mlig455_013938 | Neo: - Age: - |
ANGPT4 | 0.989 | - | - | - | - | 0.989 | - | Mlig455_013938 {REF} {Length: 1249} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=74.4]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=67.8, Expect=2e-12]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=67.8, Expect=8e-13]} {Dmel: FBgn0087011, CG41520, [Score=57.0, Expect=4e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=63.2, Expect=2e-11]} {RNA1509_12513} {RNA1310_75343} {RNA815_14194} |
65. | MligTC455_08098 | 15 | 0.31 | Mlig455_029099 | Neo: - Age: - Region-enriched R2: 8.013/0.00338 |
0.988 | - | 0.988 | - | - | - | - | Mlig455_029099 {REF} {Length: 1334} {RNA1310_58776} {RNA815_46110} | |
66. | MligTC455_10810 | 6 | 0.12 | Mlig455_069505 | Neo: - Age: - |
0.988 | - | 0.988 | - | - | - | - | Mlig455_069505 {REF} {Length: 376} {NoTransDecoderORF} {RNA1310_40761} | |
67. | MligTC455_11661 | 4 | 0.08 | Mlig455_019371, Mlig455_059103 | Neo: - Age: - |
0.988 | - | 0.988 | - | - | - | - | Mlig455_019371 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} Mlig455_059103 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} |
|
68. | MligTC455_13049 | 53 | 1.11 | Mlig455_029230, Mlig455_029252, Mlig455_035639, Mlig455_035735 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.077/0.00215 |
HTR2A | 0.988 | - | 0.988 | - | - | - | - | Mlig455_029230 {REF} {Length: 2756} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=149.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.6]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=24.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.2]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=142, Expect=3e-37]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=141, Expect=5e-37]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=138, Expect=8e-36]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=131, Expect=1e-32]} {Celegans: WBGene00004776, ser-1, SERotonin/octopamine receptor family; Serotonin receptor, [Score=120, Expect=2e-29]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=281, Expect=8e-90]} {RNA1310_91864} Mlig455_029252 {REF} {Length: 2844} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=188.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.8]; Spt20 family [PF12090.10, score=21.4]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=142, Expect=4e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=140, Expect=1e-35]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=136, Expect=2e-33]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=157, Expect=2e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=336, Expect=4e-108]} {RNA1310_91864} Mlig455_035639 {REF} {Length: 2811} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=182.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.7]; Spt20 family [PF12090.10, score=24.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=143, Expect=3e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=141, Expect=1e-35]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=133, Expect=6e-32]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=156, Expect=5e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=284, Expect=3e-88]} {RNA1310_91864} Mlig455_035735 {REF} {Length: 1469} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=140.9]; Spt20 family [PF12090.10, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=97.1, Expect=3e-21]; ENSG00000147246, HTR2C, 5-hydroxytryptamine receptor 2C, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=95.5, Expect=1e-20]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=93.2, Expect=6e-20]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=89.0, Expect=2e-18]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=115, Expect=1e-27]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=249, Expect=4e-77]} {RNA1310_91864} |
69. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 0.988 | - | 0.988 | - | - | - | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
70. | MligTC455_21684 | 5 | 0.11 | Mlig455_014284, Mlig455_014320, Mlig455_014336 | Neo: - Age: logFC(26M/2M)=-0.541 |
HECA | 0.988 | - | 0.988 | - | - | - | - | Mlig455_014284 {REF} {Length: 1986} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} Mlig455_014320 {REF} {Length: 2086} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685, RNA1509_12340} {RNA1509_12340, RNA815_9766} Mlig455_014336 {REF} {Length: 2009} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=7e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=166, Expect=6e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} |
71. | MligTC455_47927 | 43 | 0.9 | Mlig455_029720 | Neo: - Age: - |
0.988 | - | 0.988 | - | - | - | - | Mlig455_029720 {REF} {Length: 2459} {RNA1509_35671} {RNA1310_75812} {RNA815_33002} | |
72. | MligTC455_56980 | 4 | 0.09 | Mlig455_052557 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_052557 {REF} {Length: 120} {NoTransDecoderORF} | |
73. | MligTC455_00810 | 10 | 0.22 | Mlig455_049746 | Neo: - Age: - |
0.987 | - | - | - | - | 0.987 | - | Mlig455_049746 {REF} {Length: 577} {NoTransDecoderORF} {RNA1509_54430} {RNA1310_6578} {RNA815_41194.1} | |
74. | MligTC455_03321 | 25 | 0.52 | Mlig455_070046 | Neo: - Age: - |
0.987 | - | - | - | - | 0.987 | - | Mlig455_070046 {REF} {Length: 222} {NoTransDecoderORF} | |
75. | MligTC455_07201 | 6 | 0.12 | Mlig455_007914, Mlig455_008021 | Neo: - Age: - |
ATAT1 | 0.987 | - | - | - | - | 0.987 | - | Mlig455_007914 {REF} {Length: 1445} {Pfam: GNAT acetyltransferase, Mec-17 [PF05301.13, score=229.3]; Acetyltransferase (GNAT) domain [PF13508.9, score=20.1]; Acetyltransferase (GNAT) family [PF00583.27, score=19.6]} {Human: ENSG00000229061, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=177, Expect=1e-53]; ENSG00000231257, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=177, Expect=1e-53]; ENSG00000206488, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=177, Expect=1e-53]; ENSG00000234549, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=177, Expect=1e-53]; ENSG00000235658, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=177, Expect=1e-53]; ENSG00000223752, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=177, Expect=1e-53]; ENSG00000137343, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=177, Expect=1e-53]} {Mouse: ENSMUSG00000024426, Atat1, alpha tubulin acetyltransferase 1, [RH, Score=180, Expect=2e-57]} {Dmel: FBgn0035989, CG3967, [Score=140, Expect=1e-40]} {Celegans: WBGene00003178, mec-17, Alpha-tubulin N-acetyltransferase 1, [RH, Score=112, Expect=3e-30]} {Smed: dd_Smed_v6_4913_0_1, dd_Smed_v6_4913_0_1, [Score=194, Expect=1e-60]} {RNA1509_32168} {RNA1310_28025} {RNA815_24152} Mlig455_008021 {REF} {Length: 1002} {Pfam: GNAT acetyltransferase, Mec-17 [PF05301.13, score=235.8]; Acetyltransferase (GNAT) domain [PF13508.9, score=20.0]; Acetyltransferase (GNAT) family [PF00583.27, score=19.5]} {Human: ENSG00000206488, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=189, Expect=7e-59]; ENSG00000234549, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=189, Expect=7e-59]; ENSG00000235658, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=189, Expect=7e-59]; ENSG00000137343, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=189, Expect=7e-59]; ENSG00000223752, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=189, Expect=7e-59]; ENSG00000229061, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=189, Expect=7e-59]; ENSG00000231257, ATAT1, alpha tubulin acetyltransferase 1, [RH, Score=189, Expect=7e-59]} {Mouse: ENSMUSG00000024426, Atat1, alpha tubulin acetyltransferase 1, [RH, Score=194, Expect=1e-60]} {Dmel: FBgn0035989, CG3967, [RH, Score=149, Expect=5e-44]} {Celegans: WBGene00003178, mec-17, Alpha-tubulin N-acetyltransferase 1, [RH, Score=112, Expect=3e-30]} {Smed: dd_Smed_v6_4913_0_1, dd_Smed_v6_4913_0_1, [RH, Score=208, Expect=8e-66]} {RNA1509_32168} {RNA1310_28025, RNA1509_32168} {RNA1509_32168, RNA815_24152} |
76. | MligTC455_09651 | 5 | 0.09 | Mlig455_065649 | Neo: - Age: - |
0.986 | - | - | - | - | 0.986 | - | Mlig455_065649 {REF} {Length: 398} {Celegans: WBGene00015646, mlt-10, [Score=80.1, Expect=2e-18]} | |
77. | MligTC455_12116 | 106 | 2.2 | Mlig455_004661, Mlig455_004728 | Neo: - Age: Up-Up-Down |
0.986 | - | 0.986 | - | - | - | - | Mlig455_004661 {REF} {Length: 3441} {RNA1509_48407} {RNA1310_2938.1} {RNA815_14343.2} Mlig455_004728 {REF} {Length: 2670} {RNA1509_48407} {RNA1310_45267.1, RNA1509_48407} {RNA1509_48407, RNA815_58661} |
|
78. | MligTC455_18755 | 12 | 0.26 | Mlig455_057988 | Neo: - Age: - |
0.986 | - | - | - | - | 0.986 | - | Mlig455_057988 {REF} {Length: 4047} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=161.4]; WSC domain [PF01822.21, score=35.2]} {Celegans: WBGene00003168, mec-4, Degenerin mec-4, [Score=62.4, Expect=1e-09]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=60.5, Expect=4e-09]} {RNA1509_34199} {RNA1310_63630} {RNA815_45785} | |
79. | MligTC455_23422 | 14 | 0.29 | Mlig455_020850 | Neo: - Age: Down-Up-Down |
TNKS | 0.986 | - | - | - | - | 0.986 | - | Mlig455_020850 {REF} {Length: 2594} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=50.9]; Ankyrin repeat [PF00023.32, score=45.5]; Ankyrin repeat [PF13606.8, score=41.2]; Ankyrin repeats (many copies) [PF13637.8, score=37.3]; Ankyrin repeats (many copies) [PF13857.8, score=32.3]} {Human: ENSG00000173273, TNKS, tankyrase, [Score=69.7, Expect=1e-11]; ENSG00000285372, AC270292.3, tankyrase, [Score=69.7, Expect=1e-11]; ENSG00000101745, ANKRD12, ankyrin repeat domain 12, [Score=68.6, Expect=3e-11]} {Mouse: ENSMUSG00000031529, Tnks, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase, [Score=70.5, Expect=4e-12]; ENSMUSG00000034647, Ankrd12, ankyrin repeat domain 12, [Score=68.9, Expect=1e-11]} {Dmel: FBgn0036814, CG14073, [Score=66.2, Expect=7e-11]} {Celegans: WBGene00001582, gfi-2, GEI-4 (Four) Interacting protein, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_3062_0_5, dd_Smed_v6_3062_0_5, [Score=65.1, Expect=8e-12]} {RNA1509_48133} {RNA1310_6822, RNA1509_48133} {RNA1509_48133, RNA815_2586} |
80. | MligTC455_56879 | 6 | 0.12 | Mlig455_030320 | Neo: - Age: - |
0.986 | - | - | - | - | 0.986 | - | Mlig455_030320 {REF} {Length: 638} {NoTransDecoderORF} {RNA1509_15985} {RNA1310_7023} {RNA815_6936.1} | |
81. | MligTC455_10213 | 18 | 0.38 | Mlig455_064700 | Neo: - Age: - |
TYR | 0.985 | - | - | - | - | 0.985 | - | Mlig455_064700 {REF} {Length: 2321} {Pfam: Common central domain of tyrosinase [PF00264.22, score=106.3]} {Human: ENSG00000077498, TYR, tyrosinase, [Score=197, Expect=7e-57]} {Mouse: ENSMUSG00000004651, Tyr, tyrosinase, [Score=206, Expect=3e-60]} {Celegans: WBGene00016419, tyr-4, TYRosinase, [RH, Score=53.9, Expect=2e-07]} {Smed: dd_Smed_v6_18243_0_1, dd_Smed_v6_18243_0_1, [Score=230, Expect=3e-70]} {RNA1310_44823} {RNA815_19311} |
82. | MligTC455_10886 | 28 | 0.58 | Mlig455_046889 | Neo: - Age: - |
0.985 | - | - | - | - | 0.985 | - | Mlig455_046889 {REF} {Length: 1896} {NoTransDecoderORF} | |
83. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
0.985 | - | 0.985 | - | - | - | - | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
84. | MligTC455_19803 | 48 | 1 | Mlig455_020073, Mlig455_040876, Mlig455_066459, Mlig455_066460 | Neo: - Age: - |
KREMEN1, KREMEN2 | 0.984 | - | - | - | - | 0.984 | - | Mlig455_020073 {REF} {Length: 1139} {Pfam: WSC domain [PF01822.21, score=54.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=50.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=59.7, Expect=4e-10]} {RNA1509_53783} {RNA1310_60562} {RNA815_37853} Mlig455_040876 {REF} {Length: 898} {Pfam: WSC domain [PF01822.21, score=61.5]; PAN domain [PF00024.28, score=19.4]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=48.1, Expect=3e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=57.8, Expect=1e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=6e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=45.4, Expect=9e-06]} {RNA1509_53783} {RNA1310_60562} {RNA815_37853} Mlig455_066459 {REF} {Length: 1488} {Pfam: WSC domain [PF01822.21, score=54.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=50.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=59.7, Expect=4e-10]} {RNA1509_53783} {RNA1310_60562} {RNA815_37853} Mlig455_066460 {REF} {Length: 2320} {Pfam: WSC domain [PF01822.21, score=57.3]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=47.8, Expect=6e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=60.5, Expect=2e-10]} {RNA1509_53783} {RNA1310_60562} {RNA815_37853} |
85. | MligTC455_35365 | 14 | 0.29 | Mlig455_051974 | Neo: - Age: - |
NPFFR2 | 0.983 | - | - | - | - | 0.983 | - | Mlig455_051974 {REF} {Length: 1412} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=184.8]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=44.6]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=172, Expect=6e-49]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=162, Expect=3e-45]; ENSMUSG00000028778, Hcrtr1, hypocretin (orexin) receptor 1, [Score=155, Expect=7e-43]} {Dmel: FBgn0004842, RYa-R, RYamide receptor, [Score=168, Expect=3e-47]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [RH, Score=157, Expect=9e-44]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=265, Expect=5e-85]} {RNA1310_123208} {RNA815_46307} |
86. | MligTC455_46462 | 7 | 0.15 | Mlig455_025120 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_025120 {REF} {Length: 1291} | |
87. | MligTC455_50763 | 18 | 0.37 | Mlig455_057640, Mlig455_060151 | Neo: - Age: - |
0.982 | - | - | - | - | 0.982 | - | Mlig455_057640 {REF} {Length: 1837} {NoTransDecoderORF} {RNA1310_137366} Mlig455_060151 {REF} {Length: 1920} {NoTransDecoderORF} {RNA1310_137366} |
|
88. | MligTC455_08407 | 22 | 0.46 | Mlig455_043162 | Neo: - Age: - |
0.981 | - | 0.981 | - | - | - | - | Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196} | |
89. | MligTC455_49769 | 11 | 0.23 | Mlig455_004340, Mlig455_004350 | Neo: - Age: Up-Down-Down |
ANOS1 | 0.981 | - | - | - | - | 0.981 | - | Mlig455_004340 {REF} {Length: 3275} {Pfam: Fibronectin type III domain [PF00041.23, score=59.5]} {Human: ENSG00000011201, ANOS1, anosmin 1, [Score=114, Expect=6e-26]} {Dmel: FBgn0039155, Kal1, Kallmann syndrome 1, [RH, Score=83.2, Expect=2e-16]} {Celegans: WBGene00002181, kal-1, KALlmann syndrome homolog, [Score=86.3, Expect=3e-17]} {Smed: dd_Smed_v6_10075_0_1, dd_Smed_v6_10075_0_1, [Score=152, Expect=2e-38]} {RNA1509_44032} {RNA1310_20852} {RNA815_15013} Mlig455_004350 {REF} {Length: 3028} {Pfam: Fibronectin type III domain [PF00041.23, score=83.9]} {Human: ENSG00000011201, ANOS1, anosmin 1, [Score=126, Expect=1e-29]} {Dmel: FBgn0039155, Kal1, Kallmann syndrome 1, [RH, Score=85.9, Expect=4e-17]} {Celegans: WBGene00002181, kal-1, KALlmann syndrome homolog, [Score=90.1, Expect=2e-18]} {Smed: dd_Smed_v6_10075_0_1, dd_Smed_v6_10075_0_1, [Score=183, Expect=3e-48]} {RNA1509_44032} {RNA1310_20852, RNA1509_44032} {RNA1509_44032, RNA815_15013} |
90. | MligTC455_00747 | 5 | 0.1 | Mlig455_063660 | Neo: - Age: - |
0.98 | - | - | - | - | 0.980 | - | Mlig455_063660 {REF} {Length: 402} {NoTransDecoderORF} {RNA1310_88382} | |
91. | MligTC455_05913 | 13 | 0.28 | Mlig455_064325, Mlig455_064355 | Neo: - Age: - |
0.98 | - | - | - | - | 0.980 | - | Mlig455_064325 {REF} {Length: 2163} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.7]} {RNA1509_19020} {RNA1310_13852} {RNA815_7058} Mlig455_064355 {REF} {Length: 470} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=33.1]} {RNA1509_19020} {RNA1310_13852} {RNA815_7058} |
|
92. | MligTC455_13395 | 18 | 0.38 | Mlig455_061750 | Neo: - Age: - |
QRFPR | 0.98 | - | 0.980 | - | - | - | - | Mlig455_061750 {REF} {Length: 1579} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=107.1]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=99.8, Expect=2e-22]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=92.8, Expect=2e-20]} {Dmel: FBgn0050106, CCHa1-R, CCHamide-1 receptor, [Score=78.6, Expect=1e-15]} {Celegans: WBGene00021983, npr-5, NeuroPeptide Receptor family, [Score=77.4, Expect=2e-15]} {Smed: dd_Smed_v6_14520_0_1, dd_Smed_v6_14520_0_1, [Score=73.9, Expect=2e-14]} {RNA1310_103173} {RNA815_39338} |
93. | MligTC455_23239 | 32 | 0.67 | Mlig455_030867 | Neo: - Age: - |
PRKCB | 0.979 | - | 0.979 | - | - | - | - | Mlig455_030867 {REF} {Length: 3999} {Pfam: Protein kinase domain [PF00069.27, score=228.1]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=131.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=118.5]; C2 domain [PF00168.32, score=93.9]; Protein kinase C terminal domain [PF00433.26, score=35.3]; C1 domain [PF03107.18, score=22.2]; Kinase-like [PF14531.8, score=19.0]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [RH, Score=962, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [RH, Score=952, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [RH, Score=963, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [RH, Score=952, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [RH, Score=941, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [RH, Score=940, Expect=0.0]} {Smed: dd_Smed_v6_4244_0_2, dd_Smed_v6_4244_0_2, [RH, Score=1049, Expect=0.0]} {RNA1509_51260} {RNA1310_9698, RNA1509_51260} {RNA1509_51260, RNA815_24870} |
94. | MligTC455_20325 | 4 | 0.08 | Mlig455_010791 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_010791 {REF} {Length: 282} {NoTransDecoderORF} | |
95. | MligTC455_01426 | 3 | 0.06 | Mlig455_006036 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_006036 {REF} {Length: 200} {NoTransDecoderORF} | |
96. | MligTC455_01965 | 13 | 0.27 | Mlig455_003624 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_003624 {REF} {Length: 925} {NoTransDecoderORF} {RNA1509_51359} {RNA1310_110172} | |
97. | MligTC455_08724 | 7 | 0.14 | Mlig455_008878 | Neo: - Age: - |
TENT5D | 0.977 | - | 0.977 | - | - | - | - | Mlig455_008878 {REF} {Length: 2482} {Pfam: Nucleotidyltransferase [PF07984.14, score=304.0]} {Human: ENSG00000174016, TENT5D, terminal nucleotidyltransferase 5D, [Score=248, Expect=8e-77]; ENSG00000183508, TENT5C, terminal nucleotidyltransferase 5C, [Score=246, Expect=4e-76]; ENSG00000112773, TENT5A, terminal nucleotidyltransferase 5A, [Score=239, Expect=1e-72]} {Mouse: ENSMUSG00000073007, Tent5d, terminal nucleotidyltransferase 5D, [Score=244, Expect=8e-76]; ENSMUSG00000044468, Tent5c, terminal nucleotidyltransferase 5C, [Score=243, Expect=3e-75]; ENSMUSG00000032265, Tent5a, terminal nucleotidyltransferase 5A, [Score=242, Expect=2e-74]} {Dmel: FBgn0050497, CG30497, [Score=244, Expect=2e-74]} {Celegans: WBGene00004131, pqn-44, Prion-like-(Q/N-rich)-domain-bearing protein, [RH, Score=209, Expect=2e-61]} {Smed: dd_Smed_v6_11571_0_1, dd_Smed_v6_11571_0_1, [Score=254, Expect=8e-80]} {RNA1310_116080} |
98. | MligTC455_10224 | 2 | 0.05 | Mlig455_063468 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_063468 {REF} {Length: 103} {NoTransDecoderORF} | |
99. | MligTC455_23950 | 72 | 1.51 | Mlig455_015170, Mlig455_015294 | Neo: - Age: - |
0.977 | - | 0.977 | - | - | - | - | Mlig455_015170 {REF} {Length: 1690} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=49.7]} {RNA1310_34740} {RNA815_15663} Mlig455_015294 {REF} {Length: 1451} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=56.9]} {RNA1310_34740} {RNA815_15663} |
|
100. | MligTC455_46297 | 24 | 0.49 | Mlig455_035766 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_035766 {REF} {Length: 2581} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=64.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=21.4]} {Smed: dd_Smed_v6_21465_0_1, dd_Smed_v6_21465_0_1, [Score=48.1, Expect=6e-06]} {RNA1310_25666} {RNA815_22942} |